Chiavari, Italy
Chiavari, Italy

Time filter

Source Type

News Article | November 22, 2016
Site: www.eurekalert.org

An Australian-first study conducted by Monash University has found that from 2003-2013 nearly five deaths per 1000 employed Australian health care professionals were caused by drugs, with a significant association between specific professions and drug type. These deaths were more likely to involve females in their mid-40s, with a mental health condition, professional and/or personal stress and the intent to self-harm. With the aim of identifying best approaches to health care professionals' drug use and their mental health care needs, the major study investigated drug-caused deaths of health care professionals including physicians, nurses, dentists, psychologists and psychiatrists, physiotherapists, pharmacists, paramedics and veterinarians. A total of 404 drug-caused HCP deaths were reported to Australian coroners during this investigated timeframe, averaging 37 deaths per year. Head of the Drug Harm Prevention Unit at Monash's Department of Forensic Medicine, Dr Jennifer Pilgrim said the study found a significant association between specific professions and drugs of choice. "The mortality rate was highest in veterinarians, of which most involved death by suicide using potent barbiturates usually used in animal euthanasia. "Our research also observed some different trends to existing literature on occupation-specific drug choice. For example, nurses, dentists and pharmacists reportedly gravitate towards misuse of opioids however in this study, these health care professionals misused opioids along with other substances, namely benzodiazepines," Dr Pilgrim said. A mental health diagnosis and/or previous self-harm was reported in almost half the cohort and 50 per cent of the deaths were intentional self-harm deaths. The use of psychoactive drugs, both licit and illicit, is reportedly higher among medical practitioners than in the general population - a trend that was observed in this study. Numerous factors put health care professionals at a higher risk of substance abuse and premature death including high-stress jobs, access to controlled substances, long hours of practice and constant contact with the critically ill. "By analysing deaths reported to the coroner, the study provides new data of confirmed drug misuse in health care professionals and avoids the limitations of studies that rely on self-reports of drug use. "We hope that our research can help inform best approaches to health care professionals' drug use and mental health care needs," Dr Pilgrim said.


News Article | December 8, 2016
Site: www.eurekalert.org

A child mummy from the 17th century, found in a crypt underneath a Lithuanian church, was discovered to harbor the oldest known sample of the variola virus that causes smallpox. Researchers who sequenced the virus say it could help answer lingering questions about the history of smallpox, including how recently it appeared in humans (perhaps more recently than we thought) and when specific evolutionary events occurred. Their study appears December 8 in Current Biology. "There have been signs that Egyptian mummies that are 3,000 to 4,000 years old have pockmarked scarring that have been interpreted as cases of smallpox," says first author Ana Duggan, a postdoctoral fellow at the McMaster University Ancient DNA Center in Canada. "The new discoveries really throw those findings into question, and they suggest that the timeline of smallpox in human populations might be incorrect." The research team gathered the disintegrated variola virus DNA from the mummy after obtaining permission from the World Health Organization. Using RNA baits designed from existing variola sequences, the researchers targeted variola sequences found within the extracted DNA from the mummy's skin. Then they reconstructed the entire genome of the ancient strain of the virus and compared it to versions of the variola virus genome dating from the mid-1900s and before its eradication in the late 1970s. They concluded that these samples shared a common viral ancestor that originated sometime between 1588 and 1645--dates that coincide with a period of exploration, migration, and colonization that would have helped spread smallpox around the globe. "So now that we have a timeline, we have to ask whether the earlier documented historical evidence of smallpox, which goes back to Ramses V and includes everything up to the 1500s, is real," says co-author Henrik Poinar, the director of the Ancient DNA Centre at McMaster University in Canada. "Are these indeed real cases of smallpox, or are these misidentifications, which we know is very easy to do, because it is likely possible to mistake smallpox for chicken pox and measles." In addition to providing a more accurate timeline for the evolution of smallpox, the researchers were also able to identify distinct periods of viral evolution. One of the clearest instances of this occurred around the time that Edward Jenner famously developed his vaccine against the virus in the 18th century. During this period, the variola virus appears to have split into two strains, variola major and variola minor, which suggests that vaccination, which led to eradication of smallpox, may have changed the selection pressures acting on the virus and caused it to split into two strains. The researchers hope to use this work to identify how the sample they discovered in Lithuania compares to others that were sweeping throughout other countries in Europe at the same time. But in the bigger context of smallpox research, the scientists are optimistic that their work will provide a stepping stone to allow virologists to continue to trace smallpox and other DNA viruses back through time. "Now we know all the evolution of the sampled strains dates from 1650, but we still don't know when smallpox first appeared in humans, and we don't know what animal it came from, and we don't know that because we don't have any older historical samples to work with," says co-author Edward Holmes, a professor at the University of Sydney in Australia. "So this does put a new perspective on this very important disease, but it's also showing us that our historical knowledge of viruses is just the tip of the iceberg." This work was supported by the McMaster Ancient DNA Centre at McMaster University, the Department of Virology at the University of Helsinki, the Department of Anatomy, Histology and Anthropology at Vilnius University, the Marie Bashir Institute for Infectious Diseases and Biosecurity, the Department of Biochemistry and Molecular Science and Biotechnology at the University of Melbourne, the Department of History at Duke University, the Department of Biology at McMaster University, UC Irvine, the Mycroarray in Michigan, the Department of Chemical Engineering at the University of Michigan, the Center for Microbial Genetics and Genomics at Northern Arizona University, the Laboratoire d'Anthropologie Biologique Paul Broca at the PSL Research University, Helsinki University Hospital, the Department of Forensic Medicine at the University of Helsinki, the Department of Pathology at the University of Cambridge, the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University and the Humans & the Microbiome Program at the Canadian Institute for Advanced Research. Current Biology, Duggan, Marciniak, Poinar, Emery, Poinar et al: "17th Century Variola Virus Reveals the Recent History of Smallpox" http://www.cell.com/current-biology/fulltext/S0960-9822(16)31324-0 Current Biology (@CurrentBiology), published by Cell Press, is a bimonthly journal that features papers across all areas of biology. Current Biology strives to foster communication across fields of biology, both by publishing important findings of general interest and through highly accessible front matter for non-specialists. Visit: http://www. . To receive Cell Press media alerts, contact press@cell.com.


News Article | February 28, 2017
Site: www.24-7pressrelease.com

NEW YORK, NY, February 28, 2017 Yoshiaki Omura has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.With almost five decades of invaluable contributions to his field, Dr. Omura is renowned for his excellence as a medical researcher and educator. He discovered how to detect cancer from an electro-cardiogram and his work is strongly accepted worldwide. Dr. Omura will be a keynote speaker at the World Congress in Baltimore, MD, on February 20-22, 2017. Dr. Omura was also a keynote speaker on February 8, 2017 at European Parliament in Brussels, Belgium on non-invasive early diagnosis of cancer.Best recognized as the creator of the US patented non-invasive, early diagnostic method of cancer & cardiovascular diseases "Bi-Digital O-Ring Test", Dr. Omura parlays his expertise into roles at New York Medical College, where he is an adjunct professor of family and community medicine. Until 2 years ago, he has been affiliated with the Heart Disease Research Foundation, where he has been the director of medical research since 1972, the College of Physicians and Surgeons at Columbia University, where he has been a member of the alumni council since 1986, and the Ukrainian National Medical University, where he has been a professor for more than 10 years in the department of non-orthodox medicine since 1993.Dr. Omura earned an associate degree from Electrical Engineering Dept. of Nihon University, a Bachelor of Science in applied physics from Waseda University, and an MD from Yokohama City University. Upon graduation, Dr. Omura started as a rotating intern at Tokyo University Hospital and subsequently held the same role at Norwalk Hospital in Connecticut. In 1960 he joined Columbia University as a research fellow in cardiovascular surgery, which is the same year he began postgraduate studies in experimental physics. From 1961 until 1965, he worked as a resident physician in oncological surgery at Francis Delafield Hospital, then main cancer institute of Columbia University and towards the end of that role, he earned a Doctor of Science degree from the College of Physicians and Surgeons at Columbia University in Pharmaco-electrophysiology of single cardiac cell in vivo & in vitro. Dr. Omura has also worked as a visiting professor at the University of Paris, important research position at INSERM (National Institute of Health of France), visiting professor of Unviersity of Padua, Italy, visiting professor of Yonsei University in Seoul, Korea, visiting professor of Showa University of Tokyo, visiting professor of Chinese Medical School, consultant with the New York Pain Center, and vice chair for the American Board of Forensic Medicine.A diplomate through the International College of Acupuncture and Electro-Therapeutics, the American Academy of Pain Management and the American Academy of Experts in Traumatic Stress, Dr. Omura has contributed his extensive knowledge to a variety of creative works. He is the author of 9 books and has also served on the editorial board of the Scandinavian Journal of Acupuncture and Electrotherapy since 1987, as editor-in-chief of the Acupuncture & Electro-Therapeutics Research, International Journal since 1974, and Functional Neurology of Italy from 1988 until 2002. In order to remain abreast of changes in the field, he affiliates himself with the New York Cardiology Society, the American College of Angiology, the American Association of Integrative Medicine, and the life fellow of Royal Society of Medicine of England, as well as many others.A shining example of excellence in his field, Dr. Omura has achieved much throughout his long-standing career, including obtaining seven U.S. and seven Japanese patents in the medical field. In recognition of his efforts, he was named Acupuncture Scientist of the Year through the International Congress of Chinese Medicine in 1989 and earned the World First Qi Gong Scientist of the Year Award through the same organization a year later. Additionally, he has had the honor of being named to Who's Who in American Education, Who's Who in Science and Engineering and Who's Who in Medicine and Healthcare. Among the top 100 scientists by International Biographical Institute of Oxford, he was selected.To learn more about Dr. Omura, visit https://www.linkedin.com/in/yoshiaki-omura-m-d-sc-d-42436047 About Marquis Who's Who :Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com


News Article | November 7, 2016
Site: marketersmedia.com

— Acclaimed brain and spine neurosurgeon, Dr. Saeed Bajwa has been named Director of Neurosciences at United Health Services Wilson Medical Center in Johnson City, New York. A dedicated and acclaimed surgeon, Dr. Bajwa has used his vast firsthand knowledge to treat neurological conditions for decades while utilizing his commitment to serve non-profit groups. As the Director of Neurosurgery since 1995 at Southern New York NeuroSurgical Group P.C., his significant contributions in research and experience in neurosurgery and neurology have improved the quality of life for countless patients suffering from brain and spinal injuries in Southern New York. In addition, Dr. Bajwa has used his success for philanthropic purposes for many years, and continues to do so. He brings his extensive knowledge, cutting-edge treatments, and compassionate insight to this distinguished position. In January of 2016, Southern NY NeuroSurgical Group, headed by Dr. Bajwa, joined United Heath Services Medical Group, a multi-specialty group comprised of more than 250 physicians, based in Johnson City, and covering eight counties in the southern tier of New York. As Director of Neurosciences, Dr. Saeed Bajwa will be involved in marketing, enhancing patient care, and developing clinical research as well as coordinating and planning the expansion of services such as neuro-radiology, pain management, stroke care, neuro-intensive care service, and endovascular neurology. United Health Services (UHS), a prominent leader in the treatment of brain and spinal disorders for more than five decades, treats patients with neurological conditions all across the globe. Ranked as one of the top neurosurgical centers in New York, UHS is a not-for-profit health care system comprised of five general hospitals. Dr. Bajwa will be working closely with the qualified staff at UHS Wilson Medical Center to provide comprehensive care to patients with spinal cord and brain injuries, seizure disorders, and other neurological conditions. A contributor to the medical world for 30 years, Dr. Bajwa began his journey to helping others in his homeland of Pakistan, where he attended Nishtar Medical College of the University of Punjab. He pursued his career in neurosurgery after spending several years as a lecturer of Forensic Medicine and Pathology at King Edward Medical College in Lahore. After the devastating earthquake in Pakistan in 2005, Dr. Bajwa took part in treating the injured, broadening his experience and philanthropic efforts. He was recently awarded the ICNA Relief USA Award of Appreciation for his dedicated work with committee and community services. A respected professor in Neurosurgery, Dr. Bajwa received the Distinguished Teaching Award from the SUNY Health Science Center. Currently as Chairman at the Section of Neurosurgery at Lourdes Hospital as well as Wilson Hospital, and a dedicated member of the New York Medical Society, Dr. Saeed Bajwa shares his knowledge with other medical professionals. He was involved in clinical research in CyberKnife for the treatment of trigeminal neuralgia and he assisted in the development of the first CyberKnife Radiosurgery Center in New York state and also later on in Karachi, Pakistan. His expertise and activity in community philanthropy have made Dr. Bajwa one of the most sought-after neurosurgeons in New York. Dr. Saeed Bajwa -- Named One of The Leading Physicians of the World: http://www.streetinsider.com/Press+Releases/Dr.+Saeed+Bajwa+--+Named+One+of+The+Leading+Physicians+of+the+World/11676088.html Dr. Saeed Bajwa Proud Recepient of The ICNA Relief USA Award of Appreciation: http://www.abc6.com/story/33637050/dr-saeed-bajwa-proud-recepient-of-the-icna-relief-usa-award-of-appreciation For more information, please visit http://www.ICMediaDirect.com


Dublin, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Molecular Diagnostics - Technologies, Markets and Companies" to their offering. This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polymerase chain reaction (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, sequencing, mitochondrial DNA, biochips, nanotechnology and proteomic technologies. Initial applications of molecular diagnostics were mostly for infections but are now increasing in the areas of genetic disorders, preimplantation screening and cancer. Genetic screening tests, despite some restrictions is a promising area for future expansion of in vitro diagnostic market. Molecular diagnostics is being combined with therapeutics and forms an important component of integrated healthcare. Molecular diagnostic technologies are also involved in development of personalized medicine based on pharmacogenetics and pharmacogenomics. Currently, there has been a considerable interest in developing rapid diagnostic methods for for point-of-care and biowarfare agents such as anthrax. The number of companies involved in molecular diagnostics has increased remarkably during the past few years. More than 1,000 companies have been identified to be involved in developing molecular diagnostics and 342 of these are profiled in the report along with tabulation of 811 collaborations. Despite the strict regulation, most of the development in molecular diagnostics has taken place in the United States, which has the largest number of companies. The markets for molecular diagnostics technologies are difficult to estimate. Molecular diagnostics markets overlap with markets for non-molecular diagnostic technologies in the in vitro diagnostic market and are less well defined than those for pharmaceuticals. Molecular diagnostic markets are analyzed for 2015 according to technologies, applications and geographical regions. Forecasts are made up to 2025. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip and nanobiotechnology are expected to make a significant contribution to the growth of molecular diagnostics. Benefits of this report: - This report has evolved during the past 20 years, profiting from feedback by numerous readers and experts. - The most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics. - Includes profiles of 343 companies, the largest number in any report on this topic. - 600 references, cited in the report are included in the bibliography. - The text is supplemented by 101 tables and 15 figures. Key Topics Covered: Part I: Technologies & Applications Executive Summary 1. Introduction 2. Molecular Diagnostic Technologies 3. Biochips, Biosensors, and Nanobiotechnology 4. Proteomic Technologies for Molecular Diagnostics 5. Molecular Diagnosis of Genetic Disorders 6. Molecular diagnosis of cardiovascular disorders 7. Molecular Diagnosis of Infections 8. Molecular Diagnosis of Cancer 9. Molecular Diagnostics in Biopharmaceutical Industry & Healthcare 10. Molecular Diagnostics in Forensic Medicine and Biological Warfare 11. References Part II: Regulations, Markets & Companies 12. Ethics, Patents and Regulatory issues 13. Markets for Molecular Diagnostics 14. Companies involved in molecular diagnostics For more information about this report visit http://www.researchandmarkets.com/research/pqgfm8/molecular


Research and Markets has announced the addition of Jain PharmaBiotech's new report "Molecular Diagnostics - Technologies, Markets and Companies" to their offering. This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polymerase chain reaction (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, sequencing, mitochondrial DNA, biochips, nanotechnology and proteomic technologies. Initial applications of molecular diagnostics were mostly for infections but are now increasing in the areas of genetic disorders, preimplantation screening and cancer. Genetic screening tests, despite some restrictions is a promising area for future expansion of in vitro diagnostic market. Molecular diagnostics is being combined with therapeutics and forms an important component of integrated healthcare. Molecular diagnostic technologies are also involved in development of personalized medicine based on pharmacogenetics and pharmacogenomics. Currently, there has been a considerable interest in developing rapid diagnostic methods for for point-of-care and biowarfare agents such as anthrax. The number of companies involved in molecular diagnostics has increased remarkably during the past few years. More than 1,000 companies have been identified to be involved in developing molecular diagnostics and 342 of these are profiled in the report along with tabulation of 811 collaborations. Despite the strict regulation, most of the development in molecular diagnostics has taken place in the United States, which has the largest number of companies. The markets for molecular diagnostics technologies are difficult to estimate. Molecular diagnostics markets overlap with markets for non-molecular diagnostic technologies in the in vitro diagnostic market and are less well defined than those for pharmaceuticals. Molecular diagnostic markets are analyzed for 2015 according to technologies, applications and geographical regions. Forecasts are made up to 2025. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip and nanobiotechnology are expected to make a significant contribution to the growth of molecular diagnostics. Benefits of this report: - This report has evolved during the past 20 years, profiting from feedback by numerous readers and experts. - The most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics. - Includes profiles of 343 companies, the largest number in any report on this topic. - 600 references, cited in the report are included in the bibliography. - The text is supplemented by 101 tables and 15 figures. Key Topics Covered: Part I: Technologies & Applications Executive Summary 1. Introduction 2. Molecular Diagnostic Technologies 3. Biochips, Biosensors, and Nanobiotechnology 4. Proteomic Technologies for Molecular Diagnostics 5. Molecular Diagnosis of Genetic Disorders 6. Molecular diagnosis of cardiovascular disorders 7. Molecular Diagnosis of Infections 8. Molecular Diagnosis of Cancer 9. Molecular Diagnostics in Biopharmaceutical Industry & Healthcare 10. Molecular Diagnostics in Forensic Medicine and Biological Warfare 11. References Part II: Regulations, Markets & Companies 12. Ethics, Patents and Regulatory issues 13. Markets for Molecular Diagnostics 14. Companies involved in molecular diagnostics For more information about this report visit http://www.researchandmarkets.com/research/mbb45q/molecular Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716


MARINA DEL REY, CA--(Marketwired - November 10, 2016) - Dr. Andrew Campbell, the twelve-time award winner for excellence in health care and the treatment of patients, will serve as Program Chairman and featured lecturer at the Innovision conference entitled, "Gut-Brain Relationship" in Marina del Rey, California on Nov 11-12. Previously Board Certified in Family Medicine, Geriatrics, and Forensic Medicine, with over 80 peer-reviewed articles published, Dr. Campbell has transitioned to focus on holistic and naturopathic lifestyles. His keynote presentation at this conference will be an expose of his 40 years in the medical field, coupled with his most recently published book, "Silent But Deadly: Why Inflammation Kills Millions and How to Eliminate It." Dr. Campbell will also share with attendees in inspirational detail about his concentrated study, evidence-based techniques and proven results on the gut-brain relationship, concerning the history of processed foods, environmental changes, and how even some of the smells that we have come to love could make us more susceptible to sickness. Dr. Campbell continues to carry on his personal mission of putting the care back in healthcare by educating attendees on the body's need to lower the acidity of the blood to ward off heart disease, diabetes, and cancer. When asked why people have not heard more about this, Dr. Campbell said, "I am not beholden to insurance companies or big pharma. I have zero personal agenda. I'm out to speak the truth and bring you the facts." This engagement will be an unforgettable and life changing event. For more information on Dr. Andrew Campbell, check out his new website, www.drandrewcampbell.com, and also www.wellness-breakthrough.com, or email us at support@drandrewcampbell.com.


LAS VEGAS, NV--(Marketwired - December 08, 2016) - Dr. Andrew Campbell, the twelve-time award winner for excellence in health care and the treatment of patients, will be lecturing at the 24th Annual World Congress on Anti-Aging Medicine entitled, "Where All The Pieces Come Together" on December 9-11 in Las Vegas, Nevada. Previously Board Certified in Family Medicine, Geriatrics, and Forensic Medicine, with over 80 peer-reviewed articles published, Dr. Campbell has transitioned to focus on holistic and naturopathic lifestyles. His upcoming presentation at the A4M conference in Las Vegas only comes after speaking at the InnoVision conference in Scottsdale, Arizona entitled "Inflammation: Cooling The Heat," serving as Program Chairman and featured lecturer at the Innovision conference entitled, "Gut-Brain Relationship" in Marina del Rey, California, and at Lifestyle Medicine 2016 "Healthy People Healthy Planet" in Naples, Florida. In late July, he released his newest book,"Inflammation: The Key to Longevity-An Expert's Guide To Fighting Inflammation" a work that has grown from his four-decade career in the medical field. Here Dr. Campbell explains how many "medical mysteries" can be solved by simply altering the way that we live; from the foods we eat to the detergents that we buy. Along with many other top industry leaders, Dr. Campbell will continue to carry on his personal mission of putting the care back in healthcare by educating attendees on the body's need to lower the acidity of the blood to ward off heart disease, diabetes, and cancer. When asked why people have not heard more about this, Dr. Campbell said, "I am not beholden to insurance companies or big pharma. I have zero personal agenda. I'm out to speak the truth and bring you the facts." This engagement will be an unforgettable and life changing event. For more information on Dr. Andrew Campbell, check out his new website, www.drandrewcampbell.com.


The International Association of HealthCare Professionals is pleased to welcome Dr. Hugh Francis O’Donnell, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Hugh Francis O’Donnell is a General Practitioner with 37 years of experience and a vast expertise in all facets of his field, especially general medicine and forensic medicine. Dr. O’Donnell is currently serving patients at Strokestown Medical Practice, in Strokestown, Co. Roscommon, Ireland. Dr. Hugh Francis O’Donnell graduated in 1977, and offers a full range of Primary Care Services, as well as substantial practice in medico-legal work. In addition, he is currently teaching Forensic Medicine to 3rd year medical students at the National University of Ireland, in Galway. Dr. O’Donnell speaks English, Irish, basic French, German, and Arabic, which helps him to treat a wide range of patients. His work was published in the Irish High Court in 2010, and he is a Council Member of the Irish College of General Practitioners. Dr. O’Donnell attributes his great success to his hard work, and in his free time, enjoys swimming and going to the gym. Learn more about Dr. Hugh Francis O’Donnell here and be sure to read his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit http://www.findatopdoc.com


News Article | October 28, 2016
Site: www.prweb.com

Positioned as the museum to attend to learn about crime, the consequences of crime, and law enforcement in America, Alcatraz East has lined up an extensive Advisory Board whose breadth of knowledge encompasses aspects of crime and punishment in America. Bringing together experts from chief medical examiners and detectives, to military special operators and criminal investigators, Alcatraz East Crime Museum Advisory Board supports the museum’s mission to educate, entertain, and inspire. Kellie Ann Barhight has been a detective with the Ayer Police Department in Ayer, Massachusetts for over 7 years. Her primary focus is on domestic violence, elder abuse and sexual assault investigations. Her career also includes four years as a patrol officer in Randolph, Vermont. She has a Bachelor of Arts in Criminal Justice from Norwich University. A specialist in counterterrorism and law enforcement, and a former military bodyguard, Derwin J. Bradley has provided advanced tactical police training to U.S. Army Special Forces, British Army Special Forces, and police SWAT Teams. Bradley is also the author of two books, “Black and Blue: Understanding Modern Law Enforcement in your America” and “The Operator Fear No Evil,” bringing his extensive involvement law enforcement experience and training to the museum. As President, CEO, and Chairman of the Board for Leland Enterprises Inc., Ken G. Dixon brings the financial and accounting authority to the Advisory Board of Alcatraz East. With degrees in management and accounting, and decades of experience in finance, Dixon brings an understanding of business to the museum. Sandy Jones, an avid collector of 1930s outlaw memorabilia, serves as a historical expert on the museum’s board. As a researcher and historian for over 40 years, Mr. Jones has compiled quite an extensive database on the subject. Former owner of the John Dillinger Historical Society and Outlaw Museum, Jones has worked with artifacts as John Dillinger’s car, handwritten poems by Bonnie Parker, and artwork by Machine Gun Kelly. As vice president of Communications at National Center of Missing & Exploited Children (NCMEC), Avery Mann supervises the department’s three divisions - Media Relations, Digital Media and Outreach. Mann joined NCMEC in the fall of 2011. Prior to NCMEC, Mann spent 14 years with “America’s Most Wanted,” and show host (NCMEC co-founder) John Walsh. At AMW, Mann was Walsh’s publicist, the program’s spokesman, and head of media, public relations and marketing. Mann’s responsibilities included planning and coordinating Walsh’s media appearances and working with FOX and other networks to promote the show’s content. Mann was also responsible for on-air brand integration and cross promotion with FOX network advertisers. Mann’s background also includes experience with crisis communications, breaking news comment and long lead pitching. Mann holds a Bachelor of Arts in Politics & Criminology and a Master of Science in Justice. Robin Maynard is a Certified Crime Scene Investigator with 14 years experiences in Orange County, Florida, both as a Paramedic and as a CSI in the major case Forensics Unit at the Orange County Sheriff's Office. Robin brings her expertise in Fingerprinting, Blood Spatter Analysis, Crime Scene photography and more. Robin is known for her investigation on major cases including the East Side rapist, the Richard Kannanen case and the Casey Anthony case. CSI Maynard received multiple awards and recognition throughout her career to include the investigative award from the FBI for her work on the Casey Anthony case, Unit Citations from Sheriff Berry and Sheriff Demmings, as well as the Women’s Achievement Award and the National Association of Social Workers "Public Citizen of the year" Award for her volunteer service in the community. Judge Belvin Perry, Jr. is most known as the trial judge in the case State of Florida v. Casey Anthony. Perry is currently a personal injury attorney with the law firm of Morgan & Morgan. Prior to joining the Morgan Law Firm in September of 2014, he was the Chief Judge of 9th Judicial Circuit for nearly18 years and a circuit judge for nearly t24wenty-four years, before retiring in August 2014. He has served as President of the National Conference of Metropolitan Courts, the first African American Chair of the Florida Conference of Circuit Judges, and on numerous other boards, receiving many awards and honors. As a decorated combat veteran and Navy SEAL Chief, Anthony Rivera is an expert in domestic and foreign weapons, demolition and tactics. Anthony served in Operation Enduring Freedom and Operation New Dawn in the Al-Anbar Province of Iraq. He also advised Foreign Government on Special Operations Tactics, Techniques and Procedures to countries such as Pakistan, United Arab Emirates, Jordan, Oman, Yemen, Qatar, Bahrain, and several other partner forces fighting the War on Terror. Anthony’s post-active military pursuits include leadership development, mentoring and volunteering his time to members of the military and their families. Dennis Sobin spent 10 years in prison after he refused to plead guilty and accept probation for a crime he did not commit. While he was incarcerated, he used his time to work on art, learning to read music and play classical guitar. Upon his release in 2003, Dennis formed the Prisons Foundation with two other wrongly incarcerated individuals, Helen Thorne and Jim Pruitt. Funding was received from Lloyd Rubin, an international entrepreneur, art collector, and former prisoner. The Prisons Foundation exhibits art made in prison at art galleries, schools and festivals across America, publishes over 1,000 books written by prisoners, and produces prisoner‐oriented musicals and dramas at the Kennedy Center. http://www.PrisonsFoundation.org Joshua D. Stephany, MD is the Orange County Chief Medical Examiner and Division Manager of the District Nine Medical Examiner’s Office, which includes Orange and Osceola counties. Previous to his appointment, Dr. Stephany served as Interim Chief Medical Examiner, following the retirement of Dr. Jan Garavaglia (Dr. G) in May 2015. He has appeared on The Dr. G Show, and has been published in “The American Journal of Forensic Medicine and Pathology.” Among Stephany’s extensive list of credentials, he has previously served as Associate Medical Examiner to the District Nine Medical Examiner’s Office and clinical assistant professor in forensic pathology at Florida State University College of Medicine. Wyndell C. Watkins, Sr. is a retired Chief of Detectives for the Metropolitan Police Department in Washington, D.C. and author of “YouVestigate, Don’t Speculate—See What You Have Been Missing.” Chief Watkins has and continues to provide training and presentations regarding his expertise both nationally and internationally. He is also a Court Certified Expert Witness regarding investigative techniques, police policy and procedures. Additionally, he is also a licensed private investigator and expert for the TV shows “Mysteries at the Museum” and “True Crime Series.” Chief Watkins has been featured in over 100 iTunes podcasts. Jim Willett spent 30 years with the Texas prison system and retired as the warden of the historic Huntsville “Walls” Unit. He is now the director of the Prison Museum in Huntsville, Texas, and has added first hand perspective to Alcatraz East’s exhibits. About the Alcatraz East Crime Museum Alcatraz East’s mission is to provide guests of all ages with memorable insight into American history from a different perspective. Five unique galleries burrow deep into the studies of criminal intent, criminal profiles, the penal system, victims, crime prevention, forensic science, law enforcement and our justice system. The museum is 25,000 square feet spread over 2 floors and includes over 100 interactives. The museum is located at 2757 Parkway, Pigeon Forge, TN 37863. http://www.alcatrazeast.com

Loading Forensic Medicine collaborators
Loading Forensic Medicine collaborators